论文部分内容阅读
米利酮(milrinone)是一种兼有正性肌力作用和血管扩张作用的新型磷酸二酯酶Ⅲ_c(PDEⅢ_c)抑制剂,1990年上市;其强心作用较氨利酮强10～30倍,且长期应用不产生耐受性.
Milrinone is a novel phosphodiesterase III_c (PDEⅢ_c) inhibitor with positive inotropic and vasodilating effects. It was launched in 1990. Its cardiac effect is 10 to 30 times stronger than that of ammonium bromide, And long-term use does not produce tolerance.